Purchases and Sales Made in Q4 2022 in Sorrento Therapeutics, Inc. (SRNE)
This table provides information about the institutional ownership of Sorrento Therapeutics, Inc. (SRNE) during Q4 2022. The information is specifically focused on institutions that hold shares of Sorrento Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 07, 2023
Q4 2022
|
Commonwealth Equity Services, LLC
|
SELL
|
- |
-11.2K- 7.71% |
$8.28K - $20.5K
|
134K
$44.2K
|
|
Feb 13, 2023
Q4 2022
|
M&T Bank Corp
|
SELL
|
- |
-12.7K- 46.59% |
$9.41K - $23.3K
|
14.6K
$4.81K
|
|
Feb 10, 2023
Q4 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-14.6K- 12.15% |
$10.8K - $26.7K
|
105K
$34.8K
|
|
Mar 23, 2023
Q4 2022
|
ETF Managers Group, LLC
Summit, NJ |
SELL
|
- |
-15.1K- 11.4% |
$11.2K - $27.7K
|
118K
$38.8K
|
|
Feb 14, 2023
Q4 2022
|
Mariner, LLC
Overland Park, KS |
SELL
|
- |
-15.9K- 45.79% |
$11.8K - $29.1K
|
18.8K
$6.21K
|
|
Feb 01, 2023
Q4 2022
|
Slate Stone Wealth, LLC
|
SELL
|
- |
-18.9K- 46.82% |
$14K - $34.5K
|
21.4K
$7.07K
|
|
Feb 02, 2023
Q4 2022
|
Emfo, LLC
|
SELL
|
- |
-21.3K- 9.24% |
$15.8K - $39K
|
209K
$69.1K
|
|
Feb 08, 2023
Q4 2022
|
Raymond James & Associates
St Petersburg, FL |
SELL
|
- |
-34.3K- 13.33% |
$25.4K - $62.8K
|
223K
$73.6K
|
|
Feb 06, 2023
Q4 2022
|
Moors & Cabot, Inc.
Boston, MA |
SELL
|
- |
-46.8K- 79.91% |
$34.6K - $85.6K
|
11.8K
$3.88K
|
|
Feb 09, 2023
Q4 2022
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-55.8K- 67.93% |
$41.3K - $102K
|
26.4K
$8.7K
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-76.1K- 6.93% |
$56.3K - $139K
|
1.02M
$338K
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-196K- 93.57% |
$145K - $359K
|
13.5K
$4.45K
|
|
Feb 09, 2023
Q4 2022
|
Victory Capital Management Inc
|
SELL
|
- |
-231K- 82.03% |
$171K - $422K
|
50.6K
$16.7K
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-236K- 7.85% |
$175K - $432K
|
2.77M
$915K
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-236K- 7.85% |
$175K - $432K
|
2.77M
$915K
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-281K- 21.26% |
$208K - $514K
|
1.04M
$343K
|
|
Feb 13, 2023
Q4 2022
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-625K- 60.89% |
$462K - $1.14M
|
401K
$132K
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
- |
-774K- 28.7% |
$573K - $1.42M
|
1.92M
$634K
|
|
Feb 14, 2023
Q4 2022
|
Graham Capital Management, L.P.
Rowayton, CT |
SELL
|
- |
-831K- 98.35% |
$615K - $1.52M
|
13.9K
$4.6K
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-1.25M- 42.57% |
$927K - $2.29M
|
1.69M
$558K
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.35M- 87.08% |
$998K - $2.47M
|
200K
$66K
|